Fresenius Health Partners, InterWell Health and Cricket Health are joining forces to create a new value-based kidney care company valued at $2.4 billion.
Why it matters: Kidney care has historically focused on dialysis patients, but the management of the kidney disease population prior to kidney failure has remained largely untapped. The combination acknowledges that the market is ripe for transformation.
